Danuglipron (PF-06882961) in type 2 diabetes: a randomized, placebo-controlled, multiple ascending-dose phase 1 trial
Aditi R. Saxena, Donal Gorman, Ryan M. Esquejo, Arthur Bergman, Kristin Chidsey, Clare Buckeridge, David A. Griffith, Albert M. Kim
Topics & Concepts
MedicinePlaceboTolerabilityType 2 diabetesAdverse effectBlood pressureNauseaInternal medicinePharmacologyGlycemicDiabetes mellitusHeart rateMetforminEndocrinologyPathologyAlternative medicineDiabetes Treatment and ManagementPancreatic function and diabetesMetabolism, Diabetes, and Cancer